Compare ARK Genomic Revolution ETF (ARKG) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Prudential Financial Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Prudential Financial Inc trades at $115.37 (market cap $40.07B). The key difference: Prudential Financial Inc pays a 4.85% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | PRU | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $43.57 | $118.72 |
52-Week Low | $23.09 | $92.00 |
Market Cap | — | $40.07B |
Enterprise Value | — | $67.13B |
Dividend Yield | — | 4.85% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
PRU trades at $115.37, up 0.32% on the day, with a bullish technical signal and strong support at $113. The stock shows solid fundamentals with a P/E of 11.88 and net income margin of 5.5%, while recent earnings beats in Q1 2026 and dividend announcements highlight financial stability. News coverage emphasizes expansion in retirement products and international markets.
Outlook remains positive given valuation discounts and earnings momentum, though risks include volatile cash flows and high debt levels. Analyst consensus is cautious with a hold-heavy rating, but the stock's current technical strength and fundamental metrics support a steady growth trajectory for disciplined investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
